Controlling the entire cell therapy production process—from material receipt to product release—is “essential,” according to AstraZeneca, which says its new $300 million manufacturing facility will be ...
Randomized controlled trials in oncology can make or break an investigational drug, with both patient lives and pharmaceutical company profits at stake. These trials typically pit two options against ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results